- Home
- BZUN vs ACHV Comparison
BZUN vs ACHV Comparison
Compare BZUN & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZUN
- ACHV
- Stock Information
- Founded
- BZUN 2007
- ACHV N/A
- Country
- BZUN China
- ACHV United States
- Employees
- BZUN N/A
- ACHV N/A
- Industry
- BZUN Catalog/Specialty Distribution
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BZUN Consumer Discretionary
- ACHV Health Care
- Exchange
- BZUN Nasdaq
- ACHV Nasdaq
- Market Cap
- BZUN 275.9M
- ACHV 131.3M
- IPO Year
- BZUN N/A
- ACHV N/A
- Fundamental
- Price
- BZUN $4.40
- ACHV $2.87
- Analyst Decision
- BZUN Strong Buy
- ACHV Strong Buy
- Analyst Count
- BZUN 1
- ACHV 2
- Target Price
- BZUN $4.20
- ACHV $16.00
- AVG Volume (30 Days)
- BZUN 728.7K
- ACHV 1.6M
- Earning Date
- BZUN 08-28-2025
- ACHV 11-06-2025
- Dividend Yield
- BZUN N/A
- ACHV N/A
- EPS Growth
- BZUN N/A
- ACHV N/A
- EPS
- BZUN N/A
- ACHV N/A
- Revenue
- BZUN $1,349,630,922.00
- ACHV N/A
- Revenue This Year
- BZUN $6.17
- ACHV N/A
- Revenue Next Year
- BZUN $3.40
- ACHV N/A
- P/E Ratio
- BZUN N/A
- ACHV N/A
- Revenue Growth
- BZUN 7.73
- ACHV N/A
- 52 Week Low
- BZUN $2.12
- ACHV $1.84
- 52 Week High
- BZUN $4.88
- ACHV $5.31
- Technical
- Relative Strength Index (RSI)
- BZUN 65.39
- ACHV 48.01
- Support Level
- BZUN $4.32
- ACHV $2.97
- Resistance Level
- BZUN $4.67
- ACHV $3.30
- Average True Range (ATR)
- BZUN 0.34
- ACHV 0.20
- MACD
- BZUN 0.06
- ACHV -0.02
- Stochastic Oscillator
- BZUN 73.18
- ACHV 30.65
About BZUN Baozun Inc.
Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including strategy and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.